ArticleJournal for immunotherapy of cancer2022

Therapeutic efficacy of antibody-drug conjugates targeting GD2-positive tumors.

Daniel V Kalinovsky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.